Non-high-density lipoprotein cholesterol: an alternate target for lipid-lowering therapy

Preventive Cardiology
Vera Bittner

Abstract

Non-high-density lipoprotein (non-HDL) cholesterol level is determined by subtracting the high-density lipoprotein cholesterol level from the total cholesterol level and thus encompasses not only low-density lipoprotein cholesterol, but also the cholesterol contained in atherogenic, triglyceride-rich particles like remnants. This review summarizes data extracted from English-language publications accessible through MEDLINE on the population distribution of non-HDL cholesterol, its relationship to cardiovascular disease, and the potential benefits of treatment. Non-HDL cholesterol levels in the population vary by age, sex, and race and are closely linked to measures of obesity, especially visceral obesity. Several studies in populations with and without cardiovascular disease show that non-HDL cholesterol levels relate to atherosclerosis severity and subsequent cardiovascular morbidity and mortality. Preliminary data also suggest that pharmacologically induced changes in non-HDL cholesterol levels relate to prognosis. In the National Cholesterol Education Program Adult Treatment Panel III report, non-HDL cholesterol has been designated a secondary target of therapy among patients with hypertriglyceridemia.

References

Aug 5, 1988·JAMA : the Journal of the American Medical Association·V ManninenP Koskinen
Dec 1, 1984·International Journal of Epidemiology·A KeysG Farchi
Feb 28, 1994·Archives of Internal Medicine·M A DenkeS M Grundy
Apr 4, 1998·The American Journal of Cardiology·M A AustinK L Edwards
Sep 18, 1998·Current Opinion in Lipidology·A Zambon, J E Hokanson
Jun 22, 1999·Clinical Cardiology·S H Gianturco, W A Bradley
Jul 27, 2001·The American Journal of Cardiology·C M BallantyneUNKNOWN ACCESS Study Group. Atorvastatin Comparative Cholesterol Efficacy and Safety Study
May 25, 2002·Kidney International·Tetsuo ShojiYoshiki Nishizawa
Jul 12, 2002·Kidney International·Gursharan K DograAshley B Irish
Nov 13, 2002·Circulation·Vera BittnerUNKNOWN Bypass Angioplasty Revascularization Investigation
Dec 31, 2002·Journal of the American College of Cardiology·Michael H DavidsonEnrico P Veltri
Jan 24, 2003·Clinical Cardiology·Jonathan IsaacsohnYale B Mitchel
May 15, 2003·The American Journal of Cardiology·Allan D SnidermanBenoît Lamarche

❮ Previous
Next ❯

Citations

Feb 10, 2006·Disease Management : DM·W Dallas HallUNKNOWN African-American Lipid and Cardiovascular Council
Sep 26, 2007·Current Medical Research and Opinion·Kathleen M DunganJohn B Buse
Apr 28, 2012·Geriatrics & Gerontology International·Atsushi ArakiUNKNOWN Japanese Elderly Intervention Trial Research Group
Mar 28, 2013·Menopause : the Journal of the North American Menopause Society·Roisin WorsleySusan R Davis
Nov 9, 2018·Mediators of Inflammation·Fabio CacciapagliaFlorenzo Iannone
Jan 5, 2021·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Fabio CacciapagliaFlorenzo Iannone

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.